Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples